06/24/2026
🚨 PUBLIC COMMENT PERIOD NOW OPEN
A Citizen Petition has been filed by the Pharmaceutical Safety Oversight Council (PSOC), the regulatory advocacy arm of Paws Over Profits, asking the FDA to conduct a comprehensive review of Librela and related monoclonal antibody (mAb) veterinary drugs.
The FDA is now accepting public comments as part of its formal review process.
This is a rare opportunity to place your experience directly into the official FDA administrative record that regulators are required to review.
If Librela has impacted your dog in any way—or if you believe pet owners deserve greater transparency, informed consent, and regulatory oversight—you can submit a comment directly to the FDA.
⏱ Takes about 2 minutes
📢 Every comment becomes part of the official record
🔗 https://www.pawsoverprofits.org/fda-comment